uniQure
QURE
#5298
Rank
โ‚ฌ1.32 B
Marketcap
21,08ย โ‚ฌ
Share price
-0.79%
Change (1 day)
61.73%
Change (1 year)

Revenue for uniQure (QURE)

Revenue in 2026 (TTM): โ‚ฌ15.43 Million

According to uniQure's latest financial reports the company's current revenue (TTM ) is โ‚ฌ15.56 Million. In 2025 the company made a revenue of โ‚ฌ13.7 Million a decrease over the revenue in the year 2024 that were of โ‚ฌ26.06 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for uniQure from 2013 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ15.43 M12.64%
2025 โ‚ฌ13.7 M-47.42%
2024 โ‚ฌ26.06 M81.84%
2023 โ‚ฌ14.33 M-85.56%
2022 โ‚ฌ99.26 M-78.55%
2021 โ‚ฌ0.46 B1417.06%
2020 โ‚ฌ30.49 M369.25%
2019 โ‚ฌ6.49 M-34.11%
2018 โ‚ฌ9.86 M-9.7%
2017 โ‚ฌ10.92 M-54.06%
2016 โ‚ฌ23.77 M153.61%
2015 โ‚ฌ9.37 M92.59%
2014 โ‚ฌ4.86 M66.94%
2013 โ‚ฌ2.91 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
โ‚ฌ32.02 B 205,614.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ47.71 B 306,434.30%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
โ‚ฌ28.28 M 81.70%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
โ‚ฌ89.43 M 474.51%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ2.78 B 17,820.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
โ‚ฌ16.13 M 3.66%๐Ÿ‡บ๐Ÿ‡ธ USA